| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &General Counsel
1 company
Prevoznik Michael E is a SVP &General Counsel at QUEST DIAGNOSTICS INC. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $7.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2018 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 1,423 | $104.41 | $148,575.74 | -1.7% | |
| Apr 20, 2017 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sale+OE | 29,513 | $100.00 | $2,951,300.00 | -26.8% | |
| Mar 16, 2017 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sale+OE | 13,987 | $100.00 | $1,398,700.00 | -25.8% | |
| Mar 3, 2017 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 4,478 | $98.29 | $440,142.62 | -10.0% | |
| Mar 1, 2017 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 470 | $97.77 | $45,951.90 | -1.2% | |
| Feb 27, 2017 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 440 | $97.39 | $42,851.60 | -1.1% | |
| Feb 13, 2017 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 1,200 | $93.76 | $112,512.00 | -2.9% | |
| Feb 2, 2017 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sale+OE | 45,000 | $92.39 | $4,157,595.00 | -34.9% | |
| Mar 1, 2016 | DGX Quest Diagnostics Inc | SVP &General Counsel | Sell | 3,815 | $68.22 | $260,264.56 | -4.3% |